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Medical images are playing an increasingly important role in the prevention and diag-
nosis of diseases. Medical images often contain massive amounts of data. Professional
interpretation usually requires a long time of professional study and experience accumula-
tion by doctors. Therefore, the use of super storage and computing power in deep learning
as a basis can effectively process a large amount of medical data. Breast cancer brings great
harm to female patients, and early diagnosis is the most effective prevention and treatment
method, so this project will create a new optimized breast cancer auxiliary diagnosis model
based on ResNet. Analyze and process, realize medical aided diagnosis, and provide sci-





People’s health is always a very important topic. Cancer is one of the most malignant dis-
eases with the highest morbidity and mortality in the world, which seriously threatens peo-
ple’s health and life [1]. Today, the incidence of cancer continues to rise, and researchers
around the world are making every effort to create and find more effective and advanced
ways to fight and prevent cancer. Therefore, researchers around the world are participating
in the fight against cancer. Cancer has become more and more clear and complicated in
the public’s vision, forming an inevitable huge medical component. Although, researchers
and medical staff are doing their best to develop innovative drugs and medical methods to
prevent, classify and treat cancer. However, it is still far from the goal [2]. In order to
suppress the development of cancer to people; accelerate the prevention and treatment of
cancer, all aspects of society make their contribution. For example, the 21st Century Cure
Law provided 4.8 billion and the Precision Medicine Initiative [3] for Cancer Monthly Bul-
letin [4]. This method not only provides great help and encouragement to researchers, but
also greatly encourages patients.
Among them, with the continuous maturity of computer technology, medical image
recognition technology in computer technology has also been further developed, and has
been widely used in benign or malignant tumors, brain function and mental disorders, car-
diovascular and cerebrovascular diseases and other major diseases The clinical auxiliary
screening, diagnosis, classification and treatment plan have made significant contributions
[5]. Traditional machine learning mainly relies on manual feature extraction of image data,
and uses the extracted features for model training. The process is time-consuming, labori-
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ous, and unstable. But the deep learning assisted diagnosis technology can automatically
extract features and greatly improve the stability, so this project is based on CNN to identify
the benign and malignant breast tumors.
Figure 1.1: Top 10 Cancers by Rates of Cancer Deaths.
Breast cancer is the most common cause of cancer death among women. And can
be ranked second [6], as shown in Figure 1.1. According to statistics from the American
Cancer Society, approximately 25% of cancer patients are breast cancer patients. And in the
past five years, the incidence of breast cancer has increased by a certain percentage every
year [7]. There are many reasons for breast cancer, for example, oral contraceptives, short
breastfeeding time, heavy drinking, family medical history. Lots of bad habits will increase
the risk of breast cancer[8] [9]. But for most women, the current medical technology
cannot be sure about the cause of breast cancer [10], and early breast cancer does not have
the typical symptoms and characteristics, often be overlooked. However, this disease is
usually fatal to women and therefore requires very effective rapid diagnosis and effective
treatment. This has huge social benefits for the entire society and women around the world.
At present, deep learning is a very effective detection and diagnosis method.
At present, we propose use BreakHis breast cancer dataset to train and test ResNet
model, and will do a comprehensive comparison. Then, optimize the original ResNet model
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and create a new model with better performance. For the proposed method, we chose to
combine genetic algorithms. Compared with traditional algorithms, genetic algorithm can
search multiple peaks in parallel, and has good operability and global optimization features.
In addition, it only uses the objective function and the corresponding adaptive function, and
does not need other auxiliary information. So, it can effectively solve the shortcomings of
traditional algorithms. Applying this proposed method to clinical aspects can not only help
experienced doctors to quickly screen for triage diseases, diagnose more patients in a lim-
ited time, but also help doctors who cannot yet accurately judge breast cancer to conduct
breast cancer screening, saving The cost is conducive to a large-scale promotion and popu-
larization in the society. Therefore, the research in this article is of great significance to the
improvement of medical service capabilities and social development.
1.2 Significance of the Proposed Project
The beneficiaries of the project to identify malignant cancer are not only patients, but also
have a very large contribution to medical aspect. For patients, if malignant tumors can
be detected at an early stage of disease, the chance of treatment will be high. However,
at present, due to the limitations of the collected medical equipment, manual diagnosis
and reading medical films, there will still be cases of misdiagnosis, missed diagnosis and
untimely diagnosis. Through this technology, patients can obtain more efficient diagnosis
results and judgment efficiency, thereby avoiding the use of too much time in the hospital
to wait in line and wait for the time for consultation; for the medical institutions, they
have accumulated a lot of data but do not know how effective clinical use; for medical
device manufacturers, they also want to use artificial intelligence to improve the product
technology level to expand their market; for doctors, they hope to reduce the cost of reading
time and reduce the probability of misdiagnosis.
Through training and experimenting with massive medical data, learning and research
of medical images, computers can generate accurate prediction models, and provide early
3
warning and outcome evaluation for malignant diseases. This greatly solves the above-
mentioned contradictions and problems and makes a huge contribution to cancer prevention
and detection in the future.
Table 1.1: Different types of breast tumors.













We proposed a method for breast cancer recognition based on ResNet model. And use
BreakHis dataset. The BreakHis database contains microscopic biopsy images of benign
and malignant breast tumors. They are collected through clinical research, and are images
that have been distinguished by physicians, and are authoritative. There are also different
types of breast tumors. First, breast tumors are divided into benign and malignant in Ta-
ble 1.1. The types of benign tumors are adenosis (A), fibroadenoma (F), phyllodes tumor
(PT), and tubular adenona (TA); and four malignant tumors (breast cancer): carcinoma
(DC), lobular carcinoma (LC), mucinous carcinoma (MC) and papillary carcinoma (PC).
Therefore, the purpose of this project is to distinguish and identify the characteristics of
malignant tumors through medical data sets, help doctors quickly diagnose cancer, and
reduce the chance of misdiagnosis and missed diagnosis. In our experiment, we made a
comprehensive comparison between the original ResNet and the proposed method model,
including activation function, learning rate, epoch, loss function, optimization function,
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confusion matrix, accuracy, loss, F1 score, accuracy, Recall, specificity, and sensitivity.
Finally, to achieve our experimental purpose.
The second part is that the BreakHis dataset includes images of breast tumors with dif-
ferent magnifications, including 40X, 100X, 200X, and 400X. We also will use the original
ResNet and proposed method for comparison and analysis. Therefore, the impact of the
magnification under the microscope on the diagnosis of the disease is analyzed, and the
criteria for judging breast tumor diseases are also analyzed.
1.4 Purpose of Study
Medical image analysis and external performance have always been the focus of doctors.
At present, an automated structure can effectively help doctors to improve the accuracy of
recognition and judgment. It is very difficult for people to judge the type of breast cancer
only by vision, so it is very important to use machines to perform accurate image processing
and feature extraction and finally reach the level of a doctor. Each type of different breast
cancer has its own unique characteristics, and the machine can learn them and accurately
classify them is the ultimate goal of our project. Avoid the deterioration of people’s breast
cancer and lead to irreparable consequences, and help patients and doctors have a deeper
understanding and understanding of breast cancers.
1.5 Audience
This research involves multiple fields, not only for individuals but also has a huge impact on
medicine, so it has a wide and diverse target audience. Since it involves medicine, it is also
aimed at experts of the Biomedical Imaging Society. For example, for individual patients,
their early detection of diseased breast cancer will increase the chance of treatment. And
can obtain more effective diagnosis results and judgment efficiency, thereby avoiding the
disease from developing into cancer and waiting for consultation time to spend too much
time; for medical device manufacturers, using artificial intelligence to improve the technical
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level of products and expand the market; in addition, The doctor’s aspect will reduce the
time to read cases and X-rays, and reduce the possibility of misdiagnosis.
Through training and experiments on a large number of medical data, learning and
research on medical images and medical records, the machine can generate accurate pre-
diction models, and provide early warning and result evaluation of malignant diseases. This
greatly solves the above contradictions and problems, and makes great contributions to the
prevention and detection of breast malignant tumor in the future.
1.6 Motivation
Physical and mental health is necessary for normal study, work and life. Without a healthy
body, you will not be able to maintain sufficient energy for a long time, and you may even
suffer from certain diseases and cannot perform normal social activities. Malignant tumors
of the breast are an incurable disease that has had a great impact on many people’s bodies,
leading to negative emotions in many patients. In addition to the psychological impact on
the patient, it also has an impact on life, which cannot be successful in study, work and life.
Therefore, health is very important [11]. This project can not only reduce the time to judge
the health status, but also greatly improve the convenience of busy people who do not have
time to go to the hospital for detailed examination, so that patients can get timely treatment
as soon as possible. At the stage of the disease, not make the condition worse and cause
more harm. People can get feedback in a short time and get more detailed treatment in the
hospital to prevent missing the best time for diagnosis and treatment.
1.7 Evaluation Plan
The main purpose of this project is to compare original and proposed method architecture
and identify the accuracy of breast cancer, we will use the following hyperparameters to
evaluate the architecture, to show the architecture more clearly, we will use accuracy Equa-
tion 1.1, precision Equation 1.2, recall Equation 1.3, activation function, learning rate,
6
epoch, loss function, optimization function, confusion matrix, loss, F1 score, specificity






















Among them, True positive (TP) is actually a positive sample and you are predicting a
positive sample; False negative (FN) is actually a positive sample and you are predicting
a negative sample; False positive (FP) is actually a negative sample and you are predict-
ing a positive sample; and True negative (TN) is actually a negative sample and you are
predicting a negative sample.
In our experiment, the accuracy and recall affect each other. In an ideal state, we
hope to get a high accuracy and recall, but the actual situation is that these two cannot
achieve the best at the same time, they will restrict each other. If you want a high accuracy
in the experiment, the recall is low; on the contrary, the pursuit of a high recall usually
affects the accuracy. Therefore, considering the actual situation, we are dealing with the




The goal of the neural network is to build a model that can predict human health problems
based on the input of picture features. On the basis of other aspects, we hope to find a better
way to form a new architecture and have good performance in breast tumors. Finally, the
architecture was optimized so that higher and better accuracy can be achieved, thereby
creating a new architecture. At present, we are using the BreakHis breast disease data set,
and the final accuracy of this data set is 98.48%. The association between the data set and





With the development of the computer industry, research combining the medical field and
computer technology has a long history. The great success of deep learning in the field of
computer vision has inspired scholars around the world to apply it in the field of medical
analysis. Professor Wells of the Harvard Medical University pointed out in [12] that the
application of deep learning to solve medical image analysis tasks is a development trend
in this field. Deep learning technology is closely connected with medical image recog-
nition and disease recognition. In order to research and find more advanced recognition
assistance methods and innovative frameworks, researchers have conducted a lot of work
and experiments. Since 2016, a number of medical experts have summarized, commented,
and discussed the research status and problems of deep learning in medical image analysis
[13] [14] [15] [16] [17]. In the medical field, the application of deep learning algorithms in
the normal work of physicians has made rapid progress in medical academic and commer-
cial aspects. Various publications, academic articles, magazines and journals have shown a
rapid upward trend year by year. By 2019 alone, more than 10,000 academic articles will
be published on PubMed (see Figure 2.1). In addition, the review published by Medical
Image Analysis provides a more comprehensive summary and summary of the research on
deep learning in medical image classification, detection and segmentation, registration and
retrieval [18].
2.1 Convolutional Neural Network (CNN) Based Methods Compare
CNN is one of the most popular deep learning algorithms. Deep learning is a type of ma-
chine learning. The model of this algorithm directly learns and performs classification tasks
from images, videos, texts or sounds. It provides an end-to-end deep learning model. The
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Figure 2.1: Machine learning and medical imaging publications in PubMed by year through 2019
showing the exponential growth of interest in the field, as reported by the US National Library of
Medicine of the National Institutes of Health [19].
parameters in the model can be trained by traditional gradient descent methods. The trained
CNN can extract the features in the image and complete the extraction and classification
of the image features. And there is no need to preprocess the image and train the image
features. Because it is particularly suitable for classifying images using features to identify
objects, faces and scenes, and does not require manual extraction.
CNN is a special deep feedforward network, which usually includes input layer, con-
volutional layer, pooling layer, fully connected layer and output layer. However, in the
network structure, in order to make the output more accurate and feature extraction more
abundant, usually the network model uses a network model that combines multiple convo-
lutional layers and multiple pooling layers [20].
As early as the early 21st century, AlexNet proposed by Krizhevsky [21] won the first
place in the ImageNet image classification competition. After AlexNet, new convolutional
neural network models have emerged, such as the VGG model of Oxford University. At
present, its network depth has been increased to 19 layers. The model is characterized
by widening and deepening the network structure. In 2014, Google also introduced the
GoogLeNet [22] model, which initially consisted of three layers of ordinary convolutions,
followed by three sets of subnetworks, three of which had 2, 5, and 2 initial modules. Fi-
nally, there are the average pool layer and the complete connection layer. Later, Microsoft’s
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ResNet model training fusion was faster, and successfully trained hundreds or nearly thou-
sand layers of CNNs. As the depth of the convolutional neural network deepens, more
attention needs to be paid to maintaining the shortening and accuracy of the training net-
work time, so that it can better adapt to the data set required by the actual application and
improve the classification effect. From the research point of view, the future of convolu-
tional neural networks is full of infinite possibilities.
Convolutional neural networks (CNN) are based on LeNet [23], AlexNet [21], ZFNet
[24], VGG [25], Inception [22] [26], ResNet [27], Inception-ResNet [28], Xception [29],
DenseNet [20] and NASNet [30]. The following table comprehensively compares the more
classic CNN model Table 2.1.
2.2 Computer-Aided Diagnosis (CAD)
Deep learning technology can solve many medical problems to a certain extent. Although
the results also have many problems, such as poor data quality, patient privacy, and im-
proper supervision, the development of deep learning in the medical field has become un-
stoppable. Through the long-term exploration and development of many researchers and
companies, with the help of human medical experts, tumors, cardio-cerebrovascular, neu-
rology, facial features and other research fields have made good progress, and scientific
research results continue to emerge. In order to reduce the misdiagnosis and misdiagnosis
in the diagnosis process, and at the same time improve the specificity of detecting cancer,
relevant experts have proposed the method of second reading [31]. The specific method is
that two doctors diagnose the same breast X-ray picture separately, and combine the diag-
nosis results of the two doctors to give the final result, but the disadvantage of this method
is that it will consume higher costs. With the reform and prosperity of information tech-
nology, the integration of computers into medical treatment has appeared in people’s lives,
that is, computer-aided diagnosis technology.
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Table 2.1: Comparative analysis of improved CNN model
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Directly pass the input information
to the output to protect the
integrity of the information;
Entire network only needs to
learn the input and output,
simplifying the learning goals
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Computer-aided diagnosis (CAD) [31] [32] [33] technology refers to the combination
of medical imaging technology, image processing technology and computer technology to
help doctors diagnose the diseased area, reduce the probability of misdiagnosis and missed
diagnosis, and improve the sensitivity and accuracy of the diagnosis of the diseased area.
In the CAD system, the function of the computer is mainly to acquire, process, display and
understand the input medical data. Adding a CAD system to the clinical diagnosis of breast
cancer can not only maintain false positives, but also improve the accuracy [33].
Giger et al. [34] combined breast cancer and CAD systems to increase the specificity
of the diagnosis by 10%, while at the same time, the sensitivity also increased by 14%.
Kumar et al. [35] [36] proposed a CAD system for detecting liver cancer in 2013.
Among them, the CAD system is an effective computer-aided tool. Its functions include
preprocessing input medical data, fully automatic separation of diseased parts, then feature
extraction, and finally a final judgment based on the processing results, whether it is benign
or malignant. Finally, a very high accuracy is obtained, reaching 96.7%.
Vincey Jeba Malar et al. [37] proposed a CAD system for liver cancer detection in 2013.
The main optimization part is feature extraction. In order to avoid the shortcomings of
traditional algorithms, it is proposed to use the Hidden Markov Model (HMM) to complete
the experimental project, and a test rate of 96.5% is obtained.
Priyanjana et al. [38] proposed in 2013 to classify four CAD systems related to liver
diseases based on CT images. In the experiment, five different feature texture analysis
methods were used: first-order statistics (FOS), legal texture energy measurement (TEM),
spatial gray-scale dependent matrix (SGLDM), fractal dimension measurement (FDM) and
gray scale Difference matrix. For comparison and experimental purposes.
Pereira et al.[39] used the convolutional neural network architecture in the field of dis-
ease exploration and segmentation, tried a small kernel, deep network architecture, and
used data processing methods such as grayscale normalization and data enhancement to
The enhanced part and core part of the imaged brain tumor were segmented, and won the
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first place in the 2013 public challenge.
2.3 Breast Cancer Detect Method
With the development of computer technology, computers can also perceive things that
humans can perceive, such as the identification of people, the identification of pictures, the
judgment of diseases, etc. According to the development of artificial intelligence, artificial
neural networks are the most important findings. However, with the development of science
and technology, artificial neural networks will not stop at the most basic technology but will
propose a deeper learning structure on this basis [40]. From the development of many years,
the use of deep CNN to detect cancer diseases is very popular among the public, and there
are many examples. Biomedical image analysis has always been an important research area
in deep learning. In this way, diseases can be detected early and preventive measures can
be taken. Disease detection is usually preferred by viewing computer tomography images.
Computer-aided diagnosis (CAD) systems often rely on machine learning techniques to
detect cancer. The different methods and researches that have been published on breast
cancer recognition are:
Ismail et al. [41]. used the IRMA dataset to detect breast cancer, and evaluated the
VGG16 and ResNet50 deep learning model networks. The results showed that VGG16
performed better, reaching 94%. But no improvement was made on this architecture, only
make the comparison of these two architectures.
Bayramoglu et al. [42]. proposed a multi-task CNN architecture to use BreaKHis
dataset for image classification of breast cancer, and the recognition rate is about 83%.
This method is different from the method based on manual features, and can benefit from
the additional label training data in a direct way. But this method still needs to improve the
accuracy.
Teresa Araujo et al. [43]. proposed a method based on deep learning, using CNN
algorithm and CNN + SVM algorithm to classify breast images, achieving an accuracy of
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83.30%. Comparing the accuracy of the two methods, CNN + SVM performs better than
the CNN. The accuracy of the results needs to be improved, and more advanced techniques
can be combined to improve the accuracy.
Jongwon et al. [44]. proposed to use BreaKHis database to detect breast cancer based
on Google Inception v3 model. The results show that the AUC of transfer learning is 0.89.
The classification accuracy of the model for benign tumor is 0.83, and the classification
accuracy for malignant tumor is 0.89. However, this work has not been optimized, just
compare.
Abirami et al. [45] Classify breast using wavelet features and obtain a high accuracy of
93%.
Uppal and Naseem [46] used a combination of discrete cosine transform and discrete
wavelet transform to classify mammograms into three categories.
Sahiner et al.[47] used convolutional neural networks in medical image processing in
1996. In this work, the researchers extracted texture features of target tissues from breast,
and then applied volume the product neural network is used for classification. The network
contains only one input layer, two hidden layers and one output layer, which realizes the
detection of tumors and normal tissues.
In [48], the CNN model is used to segment breast images for more accurate analysis.
Jamieson et al. [49] The adaptive deconvolution network (ADN) is used to simplify the
characteristics of breast cancer into two distinctions between malignant and benign.
Mert et al. [50] For the two classification methods, radial basis function neural network
(RBFNN) with independent component analysis (ICA) was proposed to analyze breast
cancer.
Mahboubeh et al. [51]. proposed to use Inception and ResNet for detection on the TMA
dataset and BreaKHis dataset. The results show that the accuracy rates are both between
90% to 93%. The ResNet framework detects cancer up to 98.7%.
Ankit et al. [52]. proposed to use AlexNet to analyze breast cancer. Using the BreakHis
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dataset, the accuracy range is between 93.8% to 95.7%. This scheme is a simple method
that combines the transfer learning method and is only classified.
Wisconsin’s breast cancer diagnosis data set is a numerical data set obtained by the
fine needle aspiration (FNAC) method. Singh S. et al. [53] used the data in this dataset for






Breast cancer image classification and recognition research itself is a binary classification
study. The model used in this experiment is a convolutional neural network. In theory,
the more network layers, the better the extracted features. If you want to further improve
the accuracy of the model, the most direct method is to design the deepest network. The
effect of the model will get better and better. However, the actual situation does not allow
this, such as the LeNet model has only 5 layers, the AlexNet model has 8 layers, and the
VGG-16 model has 16 layers, all of which have achieved good results in the ImageNet
competition. These network models do not have hundreds of layers but still get such good
results. This is because the directly stacked network, when the network reaches a certain
depth, the model’s effect is getting worse and worse, and the model becomes difficult to
train.
In our experiment, the network model we adopted is the ResNet-50 model, because the
ResNet-50 model has excellent results in image classification. Other convolutional neural
network structures have no way to determine the optimal number of network layers, and
the ResNet-50 model can well avoid the process of finding the optimal network layer. Its
main solution is to solve the problem of gradient disappearance or gradient dispersion with
the increase of depth in the convolutional network. ResNet can simplify this problem and
bring excellent results. The training of convolutional neural networks is based on the chain
rule. As long as one of the multiplication factors is close to zero or infinite, the final result
will be close to zero or infinite. This will form a problem that the network is difficult to
train or improve, and the effect will be counterproductive.
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Figure 3.1: Residual block of deep residual network.
It can be clearly seen from the residual block shown in Figure 3.1 that the structure of
the residual block can solve the problem of gradient disappearance or gradient dispersion
caused by the chain rule from the source. For the residual structure, there is the following
relationship as Equation 3.1:
F = W2σ (W1x) (3.1)
Where σ represents the activation function ReLU, and the output is obtained through a
residual unit structure and a second activation function as Equation 3.2:
y = F (x, {Wi}) + x (3.2)
As can be seen from the formula, this greatly solves the contradiction of the traditional
convolutional neural network, and ResNet uses batch normalization and ReLU activation
unit, which reduces the training difficulty of ResNet, so we chose this network model for
our experiment.
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The characteristic of ResNet model:
1) Increase the network layer and improve the network segmentation accuracy.
2) More jump connections can be added in the middle of the network, which can better
combine the background semantic information of the image to perform multi-scale
segmentation.
3) ResNet has the advantages of rapid convergence and reducing the amount of model
data.
4) ResNet makes the model easier to train, which prevents the model from degenerating,
but also prevents the gradient from disappearing, and the loss does not converge.
3.2 Gentic Algorithm
Evolutionary algorithms are a large category, for example, includes genetic algorithms,
genetic programming, evolution strategies, and evolution programming methods. What
we want to use to improve our proposed method is the genetic algorithm. Evolutionary
algorithm (EAs), it is not a specific algorithm, but a general name and basis for a class of
algorithms based on Darwin’s theory of evolution. It does this by simulating the evolution
of biology in nature, reproduction, mutation, competition and selection. Correspondingly,
the algorithm will also generate operations such as genetic coding, population initialization,
cross-mutation operators, and management retention mechanisms [54]. Among the many
calculation methods, evolutionary calculation is a special calculation method with high
performance, so this is why we choose this optimization algorithm, it can be applied to a
variety of architectures and models, and has real-time evolution And excellent robustness
features. In addition, it can also self-adjust, so as to be more appropriately integrated into
the new architecture or model. And, to complete more powerful improvements, you can
also deal with ways that traditional methods cannot.
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In the application process, it can give a coding scheme to the entire parameter space
instead of processing specific parameters, that is to say, instead of searching from a single
initial point, it automatically adjusts the algorithm control parameters and coding accuracy.
Therefore, evolutionary algorithms are widely applicable, highly nonlinear, easy to modify,
and parallelize.
Compared with ordinary search methods, evolutionary computing is an iterative algo-
rithm. The difference is that in the search process, evolutionary computing starts from a set
of solutions to a problem and improves to another set with better results. The group issued
further improvements. Imitating biological inheritance methods, mainly adopting a series
of three operations of replication, exchange and mutation to derive the next generation of
individuals. Then, according to the size of the fitness, the survival of the fittest will be
improved, and the quality of the new generation group will be improved. After repeated
iterations, the optimal solution will be obtained. From a mathematical point of view, the
evolutionary algorithm is essentially a method of searching for optimization, as shown in
Figure 3.2.
Figure 3.2: Simplify the basic operation process of the evolutionary algorithm.
Firstly, propose a complete plan; evaluate the advantages and disadvantages of the plan;
select a part of the plan as the basis for the next steps; iterate and get results; after reaching
the goal, you will get excellent results, otherwise repeat the iterative steps, looking again
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the better plan. [55]. Evolutionary computing is a very promising method and is used
in many professional applications, such as pattern recognition, image processing, artificial
intelligence, economic management, mechanical engineering, electrical engineering, com-
munications, and biology [56]. The development of evolutionary computing is very rapid
and has been widely recognized by academia.
3.2.1 NNI (Neural Network Intelligence) Framework
In the actual operation of machine learning, a lot of manual intervention is usually required,
for example, feature extraction, model selection, parameter adjustment, etc. When we
want to create an optimized architecture, we need to make appropriate adjustments in the
above aspects and achieve more excellent results and architecture. The emergence of the
NNI framework helps researchers to no longer repeat parameter adjustments or try various
combinations of hyperparameters, but can directly help researchers automatically obtain
optimized architectures, which relate architectures to features, models, optimization, and
evaluation. The important steps are to learn automatically, without human intervention, to
obtain high-quality models to achieve the results we want.
NNI is Microsoft’s open source AutoML framework for deep neural networks [57]. It
is now an automated toolkit provided by Microsoft. By combining the NNI framework into
different neural network architectures, it can automatically use a variety of tuning algo-
rithms to distinguish the best performing neural network and hyperparameters, and support
different operating environments such as stand-alone, local multi-machine, cloud. It is very
conducive to the optimization of architecture under the condition of limited conditions. In
addition, it also provides a developer environment to facilitate users to debug NNI.
Compared with other automated machine learning tools, the advantages of the NNI
framework are [57]: 1. NNI supports most mainstream deep learning frameworks. 2. A




The rapid development of medical imaging and recognition technology reflects the strong
demand for medical information acquisition. Compared to the language or text on the
case, the image can carry more information. Medical imaging can provide a wealth of
information, and its role in medical diagnosis is increasingly prominent. However, it is
difficult to judge cancer by machine:
1) Data source: Cancer images are an important branch of medical image data. They
are built in the data collection of hospitals or medical research for many years. The
acquisition channels are special, and the process is complicated. Therefore, a set that
can fully cover the types of cancer cases and is marked by professionals. Tracking
research data is a costly task.
2) Computer processing: In the data obtained, the normal samples are usually the ma-
jority, the pathological samples are few, and the number of positive and negative
samples is unbalanced, resulting in most of the time spent in training on the normal
samples, which is a waste of time and may lead to overfitting. In order to apply exist-
ing small-scale data sets more efficiently, a lot of parameter tuning work is required.
With the development of imaging technology, medical images are widely used in vari-
ous fields of medical research and diagnosis. Common medical images include computed
tomography (CT) [58], magnetic resonance imaging (MRI) [58], ultrasound images [59],
endoscopic images [60] [61] [62], and microscope images [63]. From the perspective of
imaging signals, endoscopic images and microscope images are visible light imaging, and
usually have better resolution ability in details such as color and texture; CT images, nu-
clear magnetic resonance images, and ultrasound images are non-invasively obtained inter-
nal tissue images. Belong to non-visible light reconstruction imaging.
Microscopic image refers to cutting a certain size of diseased tissue, using hematoxylin
and eosin (H&E) and other staining methods to make the sliced tissue into a pathologi-
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cal slide, and then using microscopic imaging technology to image microscopic cells and
glands. By analyzing pathological pictures, the causes, pathogenesis, and pathogenesis of
lesions can be explored to make pathological diagnosis. The use of convolutional neural
networks to train medical images requires high data quality, and deep convolutional neural
networks extract high-latitude features, which can easily lead to redundancy and affect the
training results of the classifier. [18] So, we chose the BreakHis dataset as our experiment.
3.3.1 BreakHis Dataset
Breast Cancer Histopathology Image Classification (BreakHis) was established in cooper-
ation with P & D Lab-Pathology Anatomy and Cytopathology in Paraná, Brazil. It consists
of 7,909 microscopic images of breast tumor tissue collected from 82 patients using dif-
ferent magnifications, such as 40X, 100X, 200X, and 400X in Table 3.1. Currently, it
contains 2480 benign and 5429 malignant samples. The format of the data is 700X460
pixels, 3 channels of RGB, and 8-bit depth per channel. It is a dataset with PNG format.
The dataset BreaKHis is divided into two main categories: benign tumors and malignant
tumors. Benign means that the lesion does not meet any malignant criteria, such as obvious
cell atypia, mitosis, basement membrane destruction, metastasis, etc. Under normal cir-
cumstances, benign tumors are relatively safe. But a malignant tumor is the cancer that we
will detect. Its lesions can invade and destroy adjacent structures and spread to a distance,
eventually leading to the death of people.
Table 3.1: The detail structure of BreakHis dataset, include 7909 images of breast tumor
tissue.
Magnification Benign Malignant Total
40X 652 1370 1995
100X 644 1437 2081
200X 623 1390 2013
400X 588 1232 1820
Total of Images 2480 5429 7909
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(a) A (b) DC (c) F (d) LC
(e) MC (f) PC (g) PT (h) TA
Figure 3.3: 40X images of eight different breast tumor tissue.
In the current version, the samples present in the dataset are collected by the SOB
method, also known as partial mastectomy or resection biopsy. Compared to any needle
biopsy method, this type of procedure can remove larger sized tissue samples. The be-
nign and malignant breast tumors can be divided into different types according to the way
the tumor cells are observed under the microscope. The data set currently contains four
histologically different types of benign breast tumors: adenoma (A), fibroadenoma (F),
phyllodes tumor (PT) and renal tubular adenocarcinoma (TA); breast cancer: carcinoma
(DC), lobular carcinoma (LC), mucinous carcinoma (MC) and papillary carcinoma (PC)
in Figure 3.3 Figure 3.4 Figure 3.5 Figure 3.6. To label each image, they have unique
file information, as biopsy method, tumor classification, tumor type, patient identification,
magnification.
The optical technical parameters of the microscope include numerical aperture, resolu-
tion, magnification, depth of focus, field of view width, working distance, poor coverage,
etc. Not all of these parameters are higher, the better. They are interrelated and restrictive.
The actual use should be adjusted according to the actual situation.
Regarding the magnification of the microscope, it is not the greater the better, we need
to choose the most appropriate size for the diagnosis of breast tumors. The larger the
magnification of the microscope, the smaller the field of view, the larger the cells you see,
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(a) A (b) DC (c) F (d) LC
(e) MC (f) PC (g) PT (h) TA
Figure 3.4: 100X images of eight different breast tumor tissue.
(a) A (b) DC (c) F (d) LC
(e) MC (f) PC (g) PT (h) TA
Figure 3.5: 200X images of eight different breast tumor tissue.
but the smallest number; the smaller the magnification of the microscope, the larger the
field of view, the smaller the cells you see, but the largest number; in order to see Be clear
about the object to be observed. If the microscope magnification is larger, the structure
to be observed may not be in the field of view. Therefore, it is not better to enlarge the
magnification. It is necessary to adjust it according to the needs and choose the appropriate
magnification. Therefore, in our experiments, we will also choose the most appropriate
method for diagnosing breast tumors.
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In our project, we will conduct model building and evaluation according to the following
steps:
• Step 1: Data analysis and preprocessing.
• Step 2: Create the model.
• Step 3: Model training.
• Step 4: Model evaluation.
• Step 5: Architecture optimization.
In the experiment, the entire task was completed using the keras framework and tensorflow-
gpu. In addition, we will introduce matplotlib, pandas, numpy in python libraries; sklearn
libraries to help us complete experiments.
4.1 Data Pre-processing
Regarding the data processing part, the auxiliary diagnosis of medical diseases requires a
large amount of data, and it also needs to be updated at any time. However, at present we
have not been able to meet such standards and requirements. Therefore, I chose the dataset
with guaranteed quality and quantity, the BreakHis dataset. But this dataset is not perfect,
so we need to process it in a unified standard before using it. Because in the neural network
model, in most cases, people think that different types of data are evenly distributed, and
many algorithms are also based on this assumption. But under real circumstances, this is
often not the case. For example, the situation that the machine sends a failure is what we
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want to predict, but in fact the probability of failure is very low, so the sample size that
causes the failure is very small. Even if you set all the prediction results to normal, the
accuracy rate is still very high, but this model is a useless model, and similar examples are
very common. Therefore, we consider pre-processing in the dataset. Our experiments are
mainly from the data level.
The first is the environment used in our experiment, which requires Python3, tensorflow-
gpu and keras. Based on the needs of our experiment, we use ImageDataGenerator to pro-
cess pictures in batches. It is a picture sample intensifier. The image generated after each
sample iteration is a modified picture to achieve the purpose of data enhancement. Batches
of tensor image data are generated through real-time data enhancement, and the data will
continue to cycle. In addition, it can also expand the size of the data set and enhance
the generalization ability of the model. We will optimize the parameters Table 4.1 in the
experiment.
Table 4.1: Data processing parameters in ImageDataGenerator.
datagen = ImageDataGenerator
rotation range = rotation range,
shear range = shear range,
zoom range = zoom range,
horizontal flip = horizontal flip,
vertical flip = vertical flip
4.2 Experimental Environment
In our experiments, for the dataset in Table 4.2, we divided the dataset into 70% training
split of 5537 images, 10% validation split of 791 images, and 20% test split of 1581 images.
The following Table 4.3 provides our experimental environment:
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The residual network uses shortcut connections to solve the problem of degradation. Both
the training set and the check set prove that the deeper the network, the smaller the error
rate. Because for a neural network model, if the model is optimal, then training can easily
optimize the residual mapping to 0. At this time, only identity mapping is left, so no matter
how much depth is added, in theory the network will always be in an optimal state. Because
it is equivalent to all the additional networks behind it will transmit information along the
identity mapping, it can be understood that the layers behind the optimal network do not
have the ability to extract features, and actually have no effect. In this way, the performance
of the network will not decrease as the depth increases.
Therefore, by comparison, we chose the ResNet-50 as our experimental architecture.
First, we set the input dataset to a uniform size mode with a height of 115 and a width
of 175. Then set the parameters in the model uniformly, and set the channels to 3. In
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the original ResNet, for each layer, after each block, the number of channels becomes 4
planes, so the number of input channels for the next block should be 4 planes, so we define
self.inplanes = planes * block.expansion. The planes are unchanged, and are always the
incoming parameters, such as 64, 128, 256, and 512. It becomes the number of output
channels after each block, which means that the number of input channels of the next block
changes. The stride parameter passed in when constructing each layer is different. This
parameter represents the construction of the first block, but other blocks are not affected by
stride. In addition, it may affect the size of the feature map at this time.
In the ResNet-50 architecture, like Figure 4.1, the first layer: a total of 3 blocks, each
block has 3 layers, a total of 9 layers, are not affected by stride, that is stride=1, so the size
of the feature map is not changed; the second layer: A total of 4 blocks, each block has 3
layers, a total of 12 layers. The second layer of the first block is affected by stride, which
may change the size of the feature map, the remaining 11 layers do not change the size of
the feature map; the third layer: a total of 6 blocks, each block has 3 layers, a total of 18
layers . The second layer of the first block is affected by stride, which may change the size
of the feature map, and the remaining 17 layers do not change the size of the feature map;
the fourth layer: a total of 3 blocks, each block has 3 layers, a total of 9 layers . In order to
improve the accuracy and performance of the model, we have added additional layers for
classification. We set the parameters of layers to 2048, 512, and 32.
To solve the problem of overfitting, that is to say, the model performs well on the
training data, but performs poorly on the test data. The best way is to increase the training
data, but in the case of a certain training data, in order to prevent the model from overfitting,
we generally use the dropout method, by randomly discarding certain neurons in a layer to
achieve the purpose of reducing overfitting. Therefore, we set the dropout layer to 0.3.
The experimental parameters of our project are also given in Table 4.4:
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Figure 4.1: 50 layer ResNet architecture.
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Based on the original ResNet-50 architecture, we will optimize the original architecture.
For the evolutionary algorithm accepted earlier, we will use naive evolution from the NNI
framework to optimize the ResNet-50 architecture. The evolutionary algorithm comes from
”large-scale evolution of image classifiers” [55]. It will randomly generate an overall spa-
tial search based on the ResNet architecture. In each generation, better results will be
selected, and some mutations will be made to its next generation (for example, changing
a superparameter, adding or subtracting one layer). It can find the best combination of
parameters and improve the performance of the architecture.
Tuner in NNI framework is an automatic machine learning algorithm that will generate
a new configuration for the next trial. The new trial will run with this set of configurations.
We chose one of Naı̈ve Evolution (Naive Evolution Algorithm) to implement our experi-
ment. The naive evolutionary algorithm requires many trials to be effective, but it is also
very simple and it is easy to extend new functions. This is the method we actually applied
to the experiment.
According to the experimental steps, we first install the NNI framework. About the
realization of genetic algorithm in NNI framework, all training datasets in the search phase
are set to epoch is 30, population size is 20, concurrency is 4 and max iteration number is
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100. Therefore, the parameter settings are based on the reference values set by the NNI
framework and the content of the literature. The parameters we will search are: batch
size, learning rate, optimizer, three classification layer parameters, dropout, horizontal flip,
vertical flip, rotation range, shear range, zoom range. Because doing so can get better
results, but can control fewer calculations and shorten the search time.
Then perform a neural network search to obtain the best hyperparameters. In this pro-
cess, in addition to the function of using genetic algorithms, it also has the function of
supporting the weight migration model. After the hyperparameter search is completed, we
change the hyperparameters in the original ResNet to create a proposed method for the last
step. According to the hyperparameter search results Table 4.5, among them, we adjust the
newly added three classification layer parameters to 64, 0, 64. There is also a dropout layer
set to 0.108875.












First, in order to get a better dataset and balanced data, we first adjust the parameters
Table 4.6 in ImageDataGenerator to improve the quality of the dataset.
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The loss function is one of the most important concepts in machine learning. By calculating
the size of the loss function, it is the main basis in the machine learning process and an
important criterion to judge the merits of the algorithm after learning. Therefore, I chose
cross entropy as the basis for proposed method architecture. Cross entropy is used as a loss
function in neural networks. Among them Equation 4.1, y represents the distribution of
real labels, a is the predicted label distribution of the trained model, and the cross-entropy
loss function can measure the similarity of y and a. Another benefit of cross-entropy as a
loss function is to avoid the problem of a decrease in the learning rate of the mean square
error loss function, because the learning rate can be controlled by the output error.




[y ln a+ (1− y) ln(1− a)] (4.1)
Among them, the selected categorical crossentropy Equation 4.2 is more suitable for
multi-classification problems, and using softmax as the activation function of the output




ŷi1 log yi1 + ŷi2 log yi2+, . . . ,+ŷim log yim (4.2)
n is the number of samples and m is the number of classifications. Note that this is a
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When using the categorical crossentropy loss function, my labels are in multi-category
mode. For example, if you have 10 categories, the label of each sample should be a 10-
dimensional vector. The vector has a value of 1 in the corresponding index position and the
rest is 0. This is how our experiments are conducted.
4.4.2 Activation Function
In order to better improve the performance of the model, we chose different activation func-
tions. For the three classification layers we added, we used the ReLU activation function.
For the input layer, we used the softmax activation function. Below I will talk about their
advantages.
ReLU Activation Function
Rectified Linear Unit (ReLU) is a commonly used activation function in artificial neural
networks [64]. It usually refers to a nonlinear function represented by a ramp function
and its variants. Linear rectification is considered to have a certain biological principle,
and because it usually has a better effect than other commonly used activation functions
in practice, it is widely used in the field of computer vision artificial intelligence such as
image recognition by today’s deep neural networks [64].
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In a general sense, the linear rectification function refers to the ramp function in math-
ematics, namely Equation 4.4:
f(x) = max(0, x) (4.4)
In the neural network, the linear rectification as the activation function of the neuron
defines the linear transformation of the neuron wTx+ b after the nonlinear output. In other
words, for the input vector X from the previous neural network that enters the neuron, the






To the next layer of neurons or as the output of the entire neural network. Compared
with traditional neural network activation functions, such as logistic sigmoid, tanh hyper-
bolic functions, ReLU has the following advantages:
1) More efficient gradient descent and back propagation, avoiding the problems of gra-
dient explosion and gradient disappearance. Moreover, since the gradient of the
non-negative interval is constant, ReLU can solve the sigmoid vanishing gradient
problem, so that the convergence rate of the model is maintained at a stable state;
2) For linear functions, ReLU is more expressive, especially in deep networks;
3) For non-linear functions, the calculation gradient is super simple, which makes the
overall calculation cost of the neural network decrease;
4) Principles of biomimicry: Related brain studies have shown that the coding of biolog-
ical neurons is usually scattered and sparse. Linearity correction and regularization
can be used to debug the activity of neurons in the machine neural network.
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Softmax Activation Function
The sigmoid function and softmax function in the activation function are mainly used for
the output of the neural network output layer. The softmax function can be regarded as
a general case of the Sigmoid function, which is used for multi-classification problems.
Because the multi-classification problem is to use the softmax activation function with
the classification cross-entropy function to achieve better results, we choose the softmax
activation function as our output layer function.
The Softmax function compresses the K-dimensional real number vector into another
K-dimensional real number vector, where each element in the vector has a value between
(0, 1). Commonly used in multi-classification problems. Suppose we have an array, S,







4.5.1 Breast Cancer - 40X Result
For different microscope magnification datasets, we have done separate analysis. Below I
will show the results separately, and finally make a comprehensive comparison and sum-
mary. In the 40X dataset, using the original ResNet and the proposed method, we compared
the loss, accuracy of the training dataset and the validation dataset. The following line chart
Figure 4.2, Figure 4.3, Figure 4.4 and Figure 4.5 shows the experiment results. Compared
with the original ResNet, the proposed method has greatly improved performance and is a
very meaningful experimental project.
Table 4.7, Table 4.8, Table 4.9, Figure 4.6 shows the seven parameters in the original
ResNet and proposed method architecture in detail. By comparing the training dataset,
validation dataset and testing dataset, the proposed method experimental data has also been
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Figure 4.2: Original ResNet and proposed method 40X validation loss compare.
Figure 4.3: Original ResNet and proposed method 40X validation accuracy compare.
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Figure 4.4: Original ResNet and proposed method 40X training loss compare.
Figure 4.5: Original ResNet and proposed method 40X training accuracy compare.
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improved, which proves that our experiment the significance can improve the auxiliary
diagnosis of breast tumor diseases. The improvement of its parameters also indicates the
success of the experiment. We can intuitively see the results of our test after the training and
validation process. The accuracy of the original ResNet model can be achieved 94.17%,
while the proposed method model can be achieved 98.48%. It is increased 4.31%.












Correlation coefficient 0.9670 0.9835












Correlation coefficient 0.6592 0.9040
In order to make a more comprehensive comparison, we also conducted a horizon-
tal comparison from different types of breast tumors. The results of training Figure 4.7,
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(a) Accuracy (b) F1 Score
(c) Precision (d) Recall
(e) Sensitivity (f) Specificity
(g) Correlation Coefficient
Figure 4.6: Hyperparameters compare between original ResNet and proposed method for 40X
dataset.
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Correlation coefficient 0.6656 0.9276
validation Figure 4.8 and testing Figure 4.9 can clearly show that for four benign breast
tumors and four malignant breast tumors, the overall ResNet architecture has been opti-
mized. Performance is better than the original architecture. This phenomenon shows that
our proposed method is meaningful, it can effectively help doctors play a certain role in the
field of auxiliary medicine.
4.5.2 Breast Cancer - 100X Result
In the 100X dataset, using the original ResNet and the proposed method, we compared the
loss, accuracy of the training dataset and the validation dataset. The following line chart
Figure 4.10, Figure 4.11, Figure 4.12, and Figure 4.13 shows the experiment results. Com-
pared with the original ResNet, the proposed method has greatly improved performance
and is a very meaningful experimental project.
Table 4.10, Table 4.11, Table 4.12, Figure 4.14 shows the seven parameters in the orig-
inal ResNet and proposed method architecture in detail. By comparing the training dataset,
validation dataset and testing dataset, the proposed method experimental data has also been
improved, which proves that our experiment the significance can improve the auxiliary
diagnosis of breast tumor diseases. The improvement of its parameters also indicates the
success of the experiment. We can intuitively see the results of our test after the training and
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(a) Accuracy (b) F1 Score
(c) Precision (d) Recall
(e) Sensitivity (f) Specificity
(g) Correlation Coefficient
Figure 4.7: Original and proposed method hyperparameters compare between eight breast tumors
from 40X training dataset.
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(a) Accuracy (b) F1 Score
(c) Precision (d) Recall
(e) Sensitivity (f) Specificity
(g) Correlation Coefficient
Figure 4.8: Original and proposed method hyperparameters compare between eight breast tumors
from 40X validation dataset.
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(a) Accuracy (b) F1 Score
(c) Precision (d) Recall
(e) Sensitivity (f) Specificity
(g) Correlation Coefficient
Figure 4.9: Original and proposed method hyperparameters compare between eight breast tumors
from 40X testing dataset.
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Figure 4.10: Original ResNet and proposed method 100X validation loss compare.
Figure 4.11: Original ResNet and proposed method 100X validation accuracy compare.
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Figure 4.12: Original ResNet and proposed method 100X training loss compare.
Figure 4.13: Original ResNet and proposed method 100X training accuracy compare.
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validation process. The accuracy of the original ResNet model can be achieved 94.36%,
while the proposed method model can be achieved 97.46%. It is increased 3.1%.












Correlation coefficient 0.7860 0.9666












Correlation coefficient 0.5430 0.8962
In order to make a more comprehensive comparison, we also conducted a horizontal
comparison from different types of breast tumors. The results of training Figure 4.15, val-
idation Figure 4.16, and testing Figure 4.17 can clearly show that for four benign breast
tumors and four malignant breast tumors, the overall ResNet architecture has been opti-
mized. Performance is better than the original architecture. This phenomenon shows that
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(a) Accuracy (b) F1 Score
(c) Precision (d) Recall
(e) Sensitivity (f) Specificity
(g) Correlation Coefficient
Figure 4.14: Hyperparameters compare between original ResNet and proposed method for 100X
dataset.
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Correlation coefficient 0.6474 0.8561
our proposed method is meaningful, it can effectively help doctors play a certain role in the
field of auxiliary medicine.
4.5.3 Breast Cancer - 200X Result
In the 200X dataset, using the original ResNet and the proposed method, we compared the
loss, accuracy of the training dataset and the validation dataset. The following line chart
Figure 4.18, Figure 4.19, Figure 4.20 and Figure 4.21 shows the experiment results. Com-
pared with the original ResNet, the proposed method has greatly improved performance
and is a very meaningful experimental project.
Table 4.13, Table 4.14, Table 4.15, Figure 4.22 shows the seven parameters in the orig-
inal ResNet and proposed method architecture in detail. By comparing the training dataset,
validation dataset and testing dataset, the proposed method experimental data has also been
improved, which proves that our experiment the significance can improve the auxiliary
diagnosis of breast tumor diseases. The improvement of its parameters also indicates the
success of the experiment. We can intuitively see the results of our test after the training and
validation process. The accuracy of the original ResNet model can be achieved 93.00%,
while the proposed method model can be achieved 98.31%. It is increased 5.31%.
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(a) Accuracy (b) F1 Score
(c) Precision (d) Recall
(e) Sensitivity (f) Specificity
(g) Correlation Coefficient
Figure 4.15: Original and proposed method hyperparameters compare between eight breast tumors
from 100X training dataset.
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(a) Accuracy (b) F1 Score
(c) Precision (d) Recall
(e) Sensitivity (f) Specificity
(g) Correlation Coefficient
Figure 4.16: Original and proposed method hyperparameters compare between eight breast tumors
from 100X validation dataset.
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(a) Accuracy (b) F1 Score
(c) Precision (d) Recall
(e) Sensitivity (f) Specificity
(g) Correlation Coefficient
Figure 4.17: Original and proposed method hyperparameters compare between eight breast tumors
from 100X testing dataset.
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Figure 4.18: Original ResNet and proposed method 200X validation loss compare.
Figure 4.19: Original ResNet and proposed method 200X validation accuracy compare.
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Figure 4.20: Original ResNet and proposed method 200X training loss compare.
Figure 4.21: Original ResNet and proposed method 200X training accuracy compare.












Correlation coefficient 0.9714 0.9851
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Correlation coefficient 0.6056 0.8858












Correlation coefficient 0.5890 0.9140
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In order to make a more comprehensive comparison, we also conducted a horizontal
comparison from different types of breast tumors. The results of training Figure 4.24, val-
idationFigure 4.23, and testing Figure 4.25 can clearly show that for four benign breast
tumors and four malignant breast tumors, the overall ResNet architecture has been opti-
mized. Performance is better than the original architecture. This phenomenon shows that
our proposed method is meaningful, it can effectively help doctors play a certain role in the
field of auxiliary medicine.
4.5.4 Breast Cancer - 400X Result
For the 400X dataset, using the original ResNet and the proposed method, we compared
the loss, accuracy of the training dataset and the validation dataset. The following line chart
Figure 4.26, Figure 4.27, Figure 4.28 and Figure 4.29 shows the experiment results. Com-
pared with the original ResNet, the proposed method has greatly improved performance
and is a very meaningful experimental project.
Table 4.16, Table 4.17, Table 4.18, Figure 4.30 shows the seven parameters in the orig-
inal ResNet and proposed method architecture in detail. By comparing the training dataset,
validation dataset and testing dataset, the proposed method experimental data has also been
improved, which proves that our experiment the significance can improve the auxiliary
diagnosis of breast tumor diseases. The improvement of its parameters also indicates the
success of the experiment. We can intuitively see the results of our test after the training and
validation process. The accuracy of the original ResNet model can be achieved 90.78%,
while the proposed method model can be achieved 97.22%. It is increased 6.44%.
In order to make a more comprehensive comparison, we also conducted a horizontal
comparison from different types of breast tumors. The results of trainingFigure 4.32, val-
idationFigure 4.31, and testing Figure 4.33 can clearly show that for four benign breast
tumors and four malignant breast tumors, the overall ResNet architecture has been opti-
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(a) Accuracy (b) F1 Score
(c) Precision (d) Recall
(e) Sensitivity (f) Specificity
(g) Correlation Coefficient
Figure 4.22: Hyperparameters compare between original ResNet and proposed method for 200X
dataset.
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(a) Accuracy (b) F1 Score
(c) Precision (d) Recall
(e) Sensitivity (f) Specificity
(g) Correlation Coefficient
Figure 4.23: Original and proposed method hyperparameters compare between eight breast tumors
from 200X validation dataset.
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(a) Accuracy (b) F1 Score
(c) Precision (d) Recall
(e) Sensitivity (f) Specificity
(g) Correlation Coefficient
Figure 4.24: Original and proposed method hyperparameters compare between eight breast tumors
from 200X training dataset.
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(a) Accuracy (b) F1 Score
(c) Precision (d) Recall
(e) Sensitivity (f) Specificity
(g) Correlation Coefficient
Figure 4.25: Original and proposed method hyperparameters compare between eight breast tumors
from 200X testing dataset.
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Figure 4.26: Original ResNet and proposed method 400X validation loss compare.
Figure 4.27: Original ResNet and Proposed method 400X validation accuracy compare.












Correlation coefficient 0.5203 0.9830
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Figure 4.28: Original ResNet and proposed method 400X training loss compare.
Figure 4.29: Original ResNet and proposed method 400X training accuracy compare.












Correlation coefficient 0.5105 0.9383
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(a) Accuracy (b) F1 Score
(c) Precision (d) Recall
(e) Sensitivity (f) Specificity
(g) Correlation Coefficient
Figure 4.30: Hyperparameters compare between original ResNet and proposed method for 400X
dataset.
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Correlation coefficient 0.4383 0.8490
mized. Performance is better than the original architecture. This phenomenon shows that
our proposed method is meaningful, it can effectively help doctors play a certain role in the
field of auxiliary medicine.
4.6 Evaluation Metrics
Eight different breast tumors have different characteristics. These characteristics are what
the machine wants to learn and are the main basis for classification.
Adenosis is characterized by lobular acinar, peripheral ducts and connective tissue hy-
perplasia, and the lobular structure is basically preserved. According to different histolog-
ical changes at different development stages, it can be divided into 2 types:
1) The lobular hyperplasia is mainly manifested by the number of lobules and the num-
ber of acinar in the lobule. The epithelial cells are not significantly changed or may be
double-layered or multi-layered, and the intralobular duct may be slightly expanded.
2) Leaflet fibrosis type, the main features are interstitial fibrosis and acinar atrophy in
the leaflet. The outline of the leaflet sometimes exists, but it can also disappear,
leaving only some atrophied ducts.
Fibroadenoma Figure 4.34, the main feature is that in addition to the peripheral ducts
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(a) Accuracy (b) F1 Score
(c) Precision (d) Recall
(e) Sensitivity (f) Specificity
(g) Correlation Coefficient
Figure 4.31: Original and proposed method hyperparameters compare between eight breast tumors
from 400X validation dataset.
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(a) Accuracy (b) F1 Score
(c) Precision (d) Recall
(e) Sensitivity (f) Specificity
(g) Correlation Coefficient
Figure 4.32: Original and proposed method hyperparameters compare between eight breast tumors
from 400X training dataset.
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(a) Accuracy (b) F1 Score
(c) Precision (d) Recall
(e) Sensitivity (f) Specificity
(g) Correlation Coefficient
Figure 4.33: Original and proposed method hyperparameters compare between eight breast tumors
from 400X testing dataset.
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and acinar hyperplasia, the interstitial connective tissue also has obvious hyperplasia in the
leaflets. In the early stage, the lobule was enlarged due to the continued proliferation of
acinus; in the later stage, the connective tissue in the lobule was significantly increased,
causing the acinar to disperse and deform.
Figure 4.34: Peripheral ducts, acinars and interstitium all showed obvious hyperplasia,
some acinars and ducts expanded, and some lymphocytes infiltrated in the interstitium.
Phyllodes tumor Figure 4.35 are a group of tumors that are basically similar to fibroade-
noma, with clear boundaries and bidirectional differentiation. Its histological feature is that
the bilayer epithelial cells with fissure-like distribution are surrounded by overgrown cell-
rich mesenchymal components, forming a typical leaf-like structure. PT typically manifests
as a way of growing into the lumen, accompanied by leaf-like protrusions that protrude into
the expansion cavity. In the area in close contact with the epithelial components, the in-
terstitial cell components are more abundant and distributed in a band shape; in the loose
interstitial area, the cell density is low.
Tubular adenona of breast is usually less than 4cm in diameter. Under the microscope,
the tumor is composed of round or oval glands with a uniform size. The gland contains two
layers of epithelial cells, with few interstitial components, and may contain a small number
of lymphocytes.
Histological characteristics of lobular carcinomaFigure 4.36: The lobular structure still
exists, but it becomes larger, and the acinar cells are piled up and arranged irregularly. The
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Figure 4.35: Leaf-like protrusions protruding into the expansion cavity are typical features.
size and shape of the cells are relatively uniform, round, with intense nuclear staining, and
may have mitotic figures.
Figure 4.36: Acinar cells are stacked together and appear round.
The pathological manifestation of mucinous adenocarcinoma is that a large number of
extracellular mucus floats with solid tumors, ropes, glandular tubes, and sieve-like struc-
tural cancer tissue foci.
4.7 Discussion
The question about the magnification of the microscope is not as large as possible, we ana-
lyzed it through the table of test results in the experimental part Table 4.9,Table 4.12,Table 4.15,
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and Table 4.18, the accuracy of the test result of the dataset with a magnification of 40X
is 98.48%, the accuracy of the test result of the data set of 100X is 97.46%, the accuracy
of the test result of the data set of 200X is 98.31%, The accuracy of the test results with
the 400X data set is 97.22%, which clearly shows that the 40X size dataset is very suitable
for the auxiliary detection of breast tumors, because the magnification of the microscope is
related to the number of cells in the field of view, and the 40X size can be very good, and
shows the special characteristics of the disease. Choosing the appropriate microscope mag-
nification to conduct experiments can effectively improve the accuracy and effectiveness of
our experiments.
Figure 4.6, Figure 4.14, Figure 4.22, and Figure 4.30, the red lines in the figure rep-
resent the proposed method, and the blue lines represent original ResNet can intuitively
indicate that the proposed method is superior to the original one. The original ResNet
training dataset hyperparameters performed very well, but after the validation dataset and
the test dataset, the results were significantly reduced. Our analysis may have the follow-
ing problems: model problems, dataset problems, or overfitting problems. We generally
divide the dataset into training dataset, validation dataset and test dataset. The training
dataset is used to train the parameters of the model; the validation dataset is used to verify
the performance of different models; the test dataset is used to test the performance of the
trained model. Our dataset is collected by the official and has a detail label, which is a very
powerful source, so we believe that the quality of the dataset is not a problem. Secondly,
regarding overfitting, overfitting means that the parameters are adjusted too in line with
the sample, and the method to be solved is the same as the above problem. Adjust the
dataset samples and parameters. Regularization, dropout, redesign of the model, and early
termination of training can all be procedures to avoid overfitting. So we want to prevent
overfitting problems, we adjusted and optimized the dropout layer in proposed method.
In summary, we think that the most likely problem is the ResNet model. The perfor-
mance of a model is not due to its error on the training dataset, but whether its error on the
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test dataset is close to the error on the training dataset. That is to say, when the accuracy of
the validation dataset and the test dataset is low, it may not be a problem of the data itself,
but the model has not found the most suitable parameters and settings, and does not have
good generalization ability. Therefore, we have made a lot of parameter adjustments in the
proposed method to achieve the best model. Our proposed method model has a very good
average performance. It has shown good performance in the training dataset, validation
dataset and testing dataset, avoiding the problems mentioned above.
The linear charts of Figure 4.2, Figure 4.3, Figure 4.10, Figure 4.11, Figure 4.18, Fig-
ure 4.19, Figure 4.27 and Figure 4.26 can show that the validation loss of the original
ResNet is very unstable because the parameter is the loss value calculated by our preset
loss function, if it is unstable, it means that the model does not have good prediction ability.
Loss is used in the model to optimize parameters and achieve gradient descent. In general,
the smaller the loss, the higher the network optimization. When training through the model,
most of them indicate that the overall trend is that loss decreases and accuracy increases.
In order to maintain a stable loss, we make improvements in the proposed method architec-
ture. It can be seen that after the improvement, the trend of loss is very stable and maintains




Through a comprehensive comparison of the experimental part, the proposed method has
made significant progress relative to the original ResNet, indicating that the selected opti-
mal hyperparameters have brought significant progress to the ResNet and improved the ac-
curacy of training and testing. The proposed method can help researchers to analyze breast
tumor diseases more comprehensively and accurately, which is a very useful improvement.
Because in the neural network, in addition to finding the best weight and deviation param-
eters, it is also important to set appropriate hyperparameters. For example, the number of
neurons in each layer, the value of the batch size, the learning rate when the parameter is
updated, the weight decay coefficient, or the learning epoch. The process of finding hyper-
parameters is usually accompanied by many repeated experiments and errors, so it is very
important to find hyperparameters as efficiently as possible. This is what our project did.
By adjusting the hyperparameters in the architecture, these hyperparameters will affect
the learning speed of the neural network and the final classification results, because deep
learning usually takes a lot of time, therefore, in the process of finding hyperparameters,
it is necessary to abandon those illogical problems and use appropriate hyperparameters as
soon as possible. The table in the experimental part effectively shows that the proposed
method is superior to the original ResNet in all aspects. Although the performance of the
original ResNet is also very good, after selecting more suitable hyperparameters, you will
get even better results.
In this project, we used genetic algorithms to optimize the ResNet model and created
an proposed method model based on the BreakHis breast tumor dataset. Compared with
the original ResNet model, it has been significantly improved. For the 40X dataset, the
accuracy rate of the original ResNet model is 94.17%, and our result is improved to 98.48%;
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for the 100X dataset, the accuracy rate of the original ResNet model is 94.36%, and our
result is improved to 97.46%; For the 200X dataset, the accuracy rate of the original ResNet
model is 93.00%, and our result is improved to 98.31%; for the 400X dataset, the accuracy
rate of the original ResNet model is 90.78%, and our result is improved to 97.22%. This
is a very big improvement. This project can help doctors or patients to judge benign or
malignant breast tumors in time, which is of great significance to society.
In summary, compared to the BreakHis breast tumor dataset, the proposed method is
very useful compared to the original ResNet, and can provide very good medical aided
diagnostic methods. But medical data needs to be updated at any time, and a large amount is
required. Although the BreakHis dataset has detailed labels and high-quality images, it still
has some defects in quantity. In the training of neural network architecture, the imbalance
in the number and type of datasets has a very large impact on the results produced. It is
hoped that in the future, higher quality and quantitative breast tumor datasets can be used






os.environ[’TF CPP MIN LOG LEVEL’] = ’3’
os.environ[”CUDA VISIBLE DEVICES”] = ”1”
import numpy as np
import pandas as pd
import random
import matplotlib.pyplot as plt
import matplotlib.image as mpimg
from skimage.transform import resize
from models import *
from data processing import data split
from training fn import *
import keras
from keras.layers import *
from keras.models import *
from keras import layers
from keras.utils.data utils import get file
from keras import backend as K
from keras.callbacks import EarlyStopping, ModelCheckpoint, ReduceLROnPlateau
from keras.optimizers import Adam
from keras.preprocessing.image import ImageDataGenerator
from sklearn.linear model import LogisticRegression
from sklearn.svm import SVC
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from sklearn.feature selection import SelectFromModel
from sklearn.model selection import cross validate




import tensorflow as tf
import keras.backend.tensorflow backend as KTF









# Name list and magnification list.
magnification list = [’40X’, ’100X’, ’200X’, ’400X’]
benign list = [’adenosis’, ’fibroadenoma’, ’phyllodes tumor’, ’tubular adenoma’]
malignant list = [’ductal carcinoma’, ’lobular carcinoma’, ’mucinous carcinoma’, ’pap-
illary carcinoma’]
cancer list = benign list + malignant list
models = [vgg16 model, vgg19 model, xception model, resnet model, inception model,
inception resnet model]
model num = 3 # Select resnet as the backbone.
model name = models[model num]. name
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# Get the timestamp and set it as weight name.
timestampEND = time.strftime(”%H%M%S”) + ’’ + time.strftime(”%d%m%Y”)
weight name = ’./models/weights’ + timestampEND +’.h5’
# Hyperparameters.
# epochs = 2
# batch size = 32
# learning rate = 0.0001
# optimizer = ”ADAM”
# lr decay = 0.1
# dropout = 0.3
# layer1 = 512
# layer2 = 128
# layer3 = 32
# horizontal flip = True
# vertical flip = True
# rotation range = 10.0
# shear range = 0.2
# zoom range = 0.2
epochs = 2
batch size = 32
learning rate = 0.0001
optimizer = ”ADAM”






horizontal flip = True
vertical flip = True
rotation range = 10.0
shear range = 0.2
zoom range = 0.2
if optimizer == ”ADAM”:
optimizer type = Adam
if optimizer == ”SGD”:
optimizer type = SGD
iteration = 0
average accuracy = 0.0
for types in magnification list:
if iteration == 0:
load wt = ”Yes”
else:
load wt = ”No”
# Load data.
training images, training labels, validation images, validation labels, testing images,












# Build the model.
for i in range(len(models)):
if models[i]. name == model name:
base model = models[i]
base model = base model(image height=image height,image width=
image width,n channels=n channels,load wt=load wt)
# Add additional layers for classification.
x = base model.output
x = Dense(2048, activation = ’relu’)(x)
x = Dropout(dropout)(x)
if layer1 >0:
x = Dense(layer1, activation = ’relu’)(x)
x = Dropout(dropout)(x)
if layer2 >0:
x = Dense(layer2, activation = ’relu’)(x)
x = Dropout(dropout)(x)
if layer3 >0:
x = Dense(layer3, activation = ’relu’)(x)
out = Dense(8, activation = ’softmax’)(x)
inp = base model.input
model = Model(inp, out)
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# Get the timestamp and set it as model name.
model timestamp = time.strftime(”%H%M%S”) + ’-’ + time.strftime(”%d%m%Y”)





early stopping = EarlyStopping(patience=10, verbose=2)
model checkpoint = ModelCheckpoint(saved model name, save best only=True, ver-
bose=2)
reduce lr = ReduceLROnPlateau(factor=lr decay, patience=5, verbose=2)
history = model.fit generator(
datagen.flow(training images, training labels, batch size=batch size),
steps per epoch=len(training images) /batch size, validation data=[validation images,
validation labels],
callbacks=[early stopping, model checkpoint, reduce lr], epochs=epochs)
# history = model.fit(training images, training labels, #
validation data=[validation images, validation labels], # epochs=epochs,
# verbose = 0,
# batch size=batch size,
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# callbacks=[early stopping, model checkpoint, reduce lr])
# Load the best model.
model = keras.models.load model(saved model name, custom objects=’f1’: f1)
# Get the test metrics at last step.
test loss, test acc, test f1 = model.evaluate(testing images, testing labels)
model.save weights(weight name)
print(”The test metrics at last step: ”)
print(”The test accuracy for ” + model name + ” with magnification ”+ types +” is ”,
test acc, ” with F1 score of ”, test f1, ”
n”)
print()
# Get the average test accuracy.
average accuracy += test acc / 4.0
# Print the metrics.
if True:
# Print the training metrics.
train logits = model.predict(training images)
train pred = np.argmax(train logits, axis=1)
train true = np.argmax(training labels, axis=1)
print(”=”*15 + ” Training metrics ”.format(types) + ”=”*15)
print metrics(train true, train pred)
# Print the validation metrics.
val logits = model.predict(validation images)
val pred = np.argmax(val logits, axis=1)
val true = np.argmax(validation labels, axis=1)
print(”=”*15 + ” Valiation metrics ”.format(types) + ”=”*15)
print metrics(val true, val pred)
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# Print the test metrics.
test logits = model.predict(testing images)
test pred = np.argmax(test logits, axis=1)
test true = np.argmax(testing labels, axis=1)
print(”=”*15 + ” Test metrics ”.format(types) + ”=”*15)
print metrics(test true, test pred)






ORIGINAL RESNET SOURCE CODE
import os
os.environ[’TF CPP MIN LOG LEVEL’] = ’3’
os.environ[”CUDA VISIBLE DEVICES”] = ”1”
import nni
import numpy as np
import pandas as pd
import random
import matplotlib.pyplot as plt
import matplotlib.image as mpimg
from skimage.transform import resize
from models import *
from data processing import data split
from training fn import *
import keras
from keras.layers import *
from keras.models import *
from keras import layers
from keras.utils.data utils import get file
from keras import backend as K
from keras.callbacks import EarlyStopping, ModelCheckpoint, ReduceLROnPlateau
from keras.optimizers import Adam, SGD
from keras.preprocessing.image import ImageDataGenerator
from sklearn.linear model import LogisticRegression
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from sklearn.svm import SVC
from sklearn.feature selection import SelectFromModel
from sklearn.model selection import cross validate





import tensorflow as tf
import keras.backend.tensorflow backend as KTF
logger = logging.getLogger(’BreakHist’)
class SendMetrics(keras.callbacks.Callback):
def on epoch end(self, epoch, logs=):
nni.report intermediate result(logs[”f1”])









# Name list and magnification list.
magnification list = [’40X’, ’100X’, ’200X’, ’400X’]
benign list = [’adenosis’, ’fibroadenoma’, ’phyllodes tumor’, ’tubular adenoma’]
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malignant list = [’ductal carcinoma’, ’lobular carcinoma’, ’mucinous carcinoma’, ’pap-
illary carcinoma’]
cancer list = benign list + malignant list
# Model list.
models = [vgg16 model, vgg19 model, xception model, resnet model, inception model,
inception resnet model]
model num = 3 # Select resnet as the backbone.
model name = models[model num]. name





# Creater model dir.
if not os.path.exists(”./models/”):
os.makedirs(”./models/”)
# Get the timestamp and set it as weight name.
timestampEND = time.strftime(”%H%M%S”) + ’-’ + time.strftime(”%d%m%Y”)
weight name = ’./models/weights-’ + timestampEND +’.h5’
# Hyper-parameters.
epochs = args[’epochs’]
batch size = args[’batch size’]
learning rate = args[’learning rate’]
optimizer = args[’optimizer’]






horizontal flip = args[’horizontal flip’]
vertical flip = args[’vertical flip’]
rotation range = args[’rotation range’]
shear range = args[’shear range’]
zoom range = args[’zoom range’]
is search = args[’search’]
if optimizer == ”ADAM”:
optimizer type = Adam
if optimizer == ”SGD”:
optimizer type = SGD
iteration = 0
average f1 = 0.0
for types in magnification list:
if iteration == 0:
load wt = ”Yes”
else:
load wt = ”No”
# Load data.
training images, training labels,
validation images, validation labels,
testing images, testing labels =











# Build the model.
for i in range(len(models)):
if models[i]. name == model name:
base model = models[i]
base model = base model(image height=image height,image width
=image width,n channels=n channels,load wt=load wt)
# Add additional layers for classification.
x = base model.output
x = Dense(2048, activation = ’relu’)(x)
x = Dropout(dropout)(x)
if layer1 >0:
x = Dense(layer1, activation = ’relu’)(x)
x = Dropout(dropout)(x)
if layer2 >0:
x = Dense(layer2, activation = ’relu’)(x)
x = Dropout(dropout)(x)
if layer3 >0:
x = Dense(layer3, activation = ’relu’)(x)
out = Dense(8, activation = ’softmax’)(x)
inp = base model.input
model = Model(inp, out)
88







# Get the timestamp and set it as model name.
model timestamp = time.strftime(”%H%M%S”) + ’-’ + time.strftime(”%d%m%Y”)





early stopping = EarlyStopping(patience=10, verbose=2)
model checkpoint = ModelCheckpoint(saved model name, save best only=True, ver-
bose=2)
reduce lr = ReduceLROnPlateau(factor=lr decay, patience=5, verbose=2)
history = model.fit generator(
datagen.flow(training images, training labels, batch size=batch size),
steps per epoch=len(training images)/ batch size, validation data=[validation images,
validation labels],
callbacks=[early stopping, model checkpoint, reduce lr, SendMetrics()], epochs=epochs)
# Load the best model.
model = keras.models.load model(saved model name, custom objects=’f1’: f1)
# Get the final validation metrics at last step.
val loss, val f1, val acc = model.evaluate(validation images, validation labels)
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model.save weights(weight name)
print(”The validation metrics at last step: ”)
print(”The validation accuracy for ” + model name + ” with magnification ”+ types +”
is ”, val acc, ” with F1 score of ”, val f1, ”
n”)
print()
# Get the average val f1 score.
average f1 += val f1 / 4.0
# Print the metrics.
if not is search:
# Print the training metrics.
train logits = model.predict(training images)
train pred = np.argmax(train logits, axis=1)
train true = np.argmax(training labels, axis=1)
print(”=”*15 + ” Training metrics ”.format(types) + ”=”*15)
print metrics(train true, train pred)
# Print the validation metrics.
val logits = model.predict(validation images)
val pred = np.argmax(val logits, axis=1)
val true = np.argmax(validation labels, axis=1)
print(”=”*15 + ” Valiation metrics ”.format(types) + ”=”*15)
print metrics(val true, val pred)
# Print the test metrics.
test logits = model.predict(testing images)
test pred = np.argmax(test logits, axis=1)
test true = np.argmax(testing labels, axis=1)
print(”=”*15 + ” Test metrics ”.format(types) + ”=”*15)
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print metrics(test true, test pred)




# report final result
nni.report final result(average f1)
if is search:





# For model architecture.
parser.add argument(”–layer1”, type=int, default=2048)
parser.add argument(”–layer2”, type=int, default=512)
parser.add argument(”–layer3”, type=int, default=32)
parser.add argument(”–dropout”, type=float, default=0.3)
# For training hyper-parameters.
parser.add argument(’–batch size’, type=int, default=64)
parser.add argument(’–learning rate’, type=float, default=0.001)
parser.add argument(’–lr decay’, type=float, default=0.1)
parser.add argument(’–optimizer’, type=str, default=”ADAM”)
parser.add argument(’–epochs’, type=int, default=30)
# For data augmentation.
parser.add argument(’–horizontal flip’, type=bool, default=False)
parser.add argument(’–vertical flip’, type=bool, default=False)
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parser.add argument(’–rotation range’, type=float, default=0.0)
parser.add argument(’–shear range’, type=float, default=0)
parser.add argument(’–zoom range’, type=float, default=0)
# Identify the phase: train or search.
parser.add argument(’–search’, type=bool, default=False)
args, = parser.parse known args()
return args
if name == ’ main ’:
try:
# get parameters form tuner
tuner params = nni.get next parameter()
params = vars(get params())
params.update(tuner params)
main(params)





PROPOSED METHOD SOURCE CODE
import os
os.environ[’TF CPP MIN LOG LEVEL’] = ’3’
os.environ[”CUDA VISIBLE DEVICES”] = ”1”
import nni
import numpy as np
import pandas as pd
import random
import matplotlib.pyplot as plt
import matplotlib.image as mpimg
from skimage.transform import resize
from models import *
from data processing import data split
from training fn import *
import keras
from keras.layers import *
from keras.models import *
from keras import layers
from keras.utils.data utils import get file
from keras import backend as K
from keras.callbacks import EarlyStopping, ModelCheckpoint, ReduceLROnPlateau
from keras.optimizers import Adam, SGD
from keras.preprocessing.image import ImageDataGenerator
from sklearn.linear model import LogisticRegression
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from sklearn.svm import SVC
from sklearn.feature selection import SelectFromModel
from sklearn.model selection import cross validate





import tensorflow as tf
import keras.backend.tensorflow backend as KTF
logger = logging.getLogger(’BreakHist’)
class SendMetrics(keras.callbacks.Callback):
def on epoch end(self, epoch, logs=):
nni.report intermediate result(logs[”f1”])









# Name list and magnification list.
magnification list = [’40X’, ’100X’, ’200X’, ’400X’]
benign list = [’adenosis’, ’fibroadenoma’, ’phyllodes tumor’, ’tubular adenoma’]
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malignant list = [’ductal carcinoma’, ’lobular carcinoma’, ’mucinous carcinoma’, ’pap-
illary carcinoma’]
cancer list = benign list + malignant list
# Model list.
models = [vgg16 model, vgg19 model, xception model, resnet model, inception model,
inception resnet model]
model num = 3 # Select resnet as the backbone.
model name = models[model num]. name





# Creater model dir.
if not os.path.exists(”./models/”):
os.makedirs(”./models/”)
# Get the timestamp and set it as weight name.
timestampEND = time.strftime(”%H%M%S”) + ’-’ + time.strftime(”%d%m%Y”)
weight name = ’./models/weights-’ + timestampEND +’.h5’
# Hyper-parameters.
epochs = args[’epochs’]
batch size = args[’batch size’]
learning rate = args[’learning rate’]
optimizer = args[’optimizer’]






horizontal flip = args[’horizontal flip’]
vertical flip = args[’vertical flip’]
rotation range = args[’rotation range’]
shear range = args[’shear range’]
zoom range = args[’zoom range’]
is search = args[’search’]
if optimizer == ”ADAM”:
optimizer type = Adam
if optimizer == ”SGD”:
optimizer type = SGD
iteration = 0
average f1 = 0.0
for types in magnification list:
if iteration == 0:
load wt = ”Yes”
else:
load wt = ”No”
# Load data.
training images, training labels,
validation images, validation labels,
testing images, testing labels =











# Build the model.
for i in range(len(models)):
if models[i]. name == model name:
base model = models[i]
base model = base model(image height=image height,image width
=image width,n channels=n channels,load wt=load wt)
# Add additional layers for classification.
x = base model.output
x = Dense(2048, activation = ’relu’)(x)
x = Dropout(dropout)(x)
if layer1 >0:
x = Dense(layer1, activation = ’relu’)(x)
x = Dropout(dropout)(x)
if layer2 >0:
x = Dense(layer2, activation = ’relu’)(x)
x = Dropout(dropout)(x)
if layer3 >0:
x = Dense(layer3, activation = ’relu’)(x)
out = Dense(8, activation = ’softmax’)(x)
inp = base model.input
model = Model(inp, out)
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# Get the timestamp and set it as model name.
model timestamp = time.strftime(”%H%M%S”) + ’-’ + time.strftime(”%d%m%Y”)





early stopping = EarlyStopping(patience=10, verbose=2)
model checkpoint = ModelCheckpoint(saved model name, save best only=True, ver-
bose=2)
reduce lr = ReduceLROnPlateau(factor=lr decay, patience=5, verbose=2)
history = model.fit generator(
datagen.flow(training images, training labels, batch size=batch size),
steps per epoch=len(training images) / batch size,
validation data=[validation images, validation labels],
callbacks=[early stopping, model checkpoint, reduce lr, SendMetrics()],
epochs=epochs)
# Load the best model.
model = keras.models.load model(saved model name, custom objects=’f1’: f1)
# Get the final validation metrics at last step.
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val loss, val f1, val acc = model.evaluate(validation images, validation labels)
model.save weights(weight name)
print(”The validation metrics at last step: ”)
print(”The validation accuracy for ” + model name + ” with magnification ”+ types +”
is ”, val acc, ” with F1 score of ”, val f1, ”
n”)
print()
# Get the average val f1 score.
average f1 += val f1 / 4.0
# Print the metrics.
if not is search:
# Print the training metrics.
train logits = model.predict(training images)
train pred = np.argmax(train logits, axis=1)
train true = np.argmax(training labels, axis=1)
print(”=”*15 + ” Training metrics ”.format(types) + ”=”*15)
print metrics(train true, train pred)
# Print the validation metrics.
val logits = model.predict(validation images)
val pred = np.argmax(val logits, axis=1)
val true = np.argmax(validation labels, axis=1)
print(”=”*15 + ” Valiation metrics ”.format(types) + ”=”*15)
print metrics(val true, val pred)
# Print the test metrics.
test logits = model.predict(testing images)
test pred = np.argmax(test logits, axis=1)
test true = np.argmax(testing labels, axis=1)
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print(”=”*15 + ” Test metrics ”.format(types) + ”=”*15)
print metrics(test true, test pred)




# report final result
nni.report final result(average f1)
if is search:





# For model architecture.
parser.add argument(”–layer1”, type=int, default=64)
parser.add argument(”–layer2”, type=int, default=0)
parser.add argument(”–layer3”, type=int, default=64)
parser.add argument(”–dropout”, type=float, default=0.10887510008284884)
# For training hyper-parameters.
parser.add argument(’–batch size’, type=int, default=16)
parser.add argument(’–learning rate’, type=float, default=0.0001)
parser.add argument(’–lr decay’, type=float, default=0.5)
parser.add argument(’–optimizer’, type=str, default=”ADAM”)
parser.add argument(’–epochs’, type=int, default=30)
# For data augmentation.
parser.add argument(’–horizontal flip’, type=bool, default=False)
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parser.add argument(’–vertical flip’, type=bool, default=True)
parser.add argument(’–rotation range’, type=float, default=20)
parser.add argument(’–shear range’, type=float, default=0.06663526112980617)
parser.add argument(’–zoom range’, type=float, default=0.48854077282376673)
# Identify the phase: train or search.
parser.add argument(’–search’, type=bool, default=False)
args, = parser.parse known args()
return args
if name == ’ main ’:
try:
# get parameters form tuner
tuner params = nni.get next parameter()
params = vars(get params())
params.update(tuner params)
main(params)







os.environ[’TF CPP MIN LOG LEVEL’] = ’3’
os.environ[”CUDA VISIBLE DEVICES”] = ”1”
import nni
import numpy as np
import pandas as pd
import random
import matplotlib.pyplot as plt
import matplotlib.image as mpimg
from skimage.transform import resize
from models import *
from data processing import data split
from training fn import *
import keras
from keras.layers import *
from keras.models import *
from keras import layers
from keras.utils.data utils import get file
from keras import backend as K
from keras.callbacks import EarlyStopping, ModelCheckpoint, ReduceLROnPlateau
from keras.optimizers import Adam, SGD
from keras.preprocessing.image import ImageDataGenerator
from sklearn.linear model import LogisticRegression
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from sklearn.svm import SVC
from sklearn.feature selection import SelectFromModel
from sklearn.model selection import cross validate





import tensorflow as tf
import keras.backend.tensorflow backend as KTF
logger = logging.getLogger(’BreakHist’)
class SendMetrics(keras.callbacks.Callback):
def on epoch end(self, epoch, logs=):
nni.report intermediate result(logs[”f1”])









# Name list and magnification list.
magnification list = [’40X’, ’100X’, ’200X’, ’400X’]
benign list = [’adenosis’, ’fibroadenoma’, ’phyllodes tumor’, ’tubular adenoma’]
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malignant list = [’ductal carcinoma’, ’lobular carcinoma’, ’mucinous carcinoma’, ’pap-
illary carcinoma’]
cancer list = benign list + malignant list
# Model list.
models = [vgg16 model, vgg19 model, xception model, resnet model, inception model,
inception resnet model]
model num = 3 # Select resnet as the backbone.
model name = models[model num]. name





# Creater model dir.
if not os.path.exists(”./models/”):
os.makedirs(”./models/”)
# Get the timestamp and set it as weight name.
timestampEND = time.strftime(”%H%M%S”) + ’-’ + time.strftime(”%d%m%Y”)
weight name = ’./models/weights-’ + timestampEND +’.h5’
# Hyper-parameters.
epochs = args[’epochs’]
batch size = args[’batch size’]
learning rate = args[’learning rate’]
optimizer = args[’optimizer’]






horizontal flip = args[’horizontal flip’]
vertical flip = args[’vertical flip’]
rotation range = args[’rotation range’]
shear range = args[’shear range’]
zoom range = args[’zoom range’]
is search = args[’search’]
if optimizer == ”ADAM”:
optimizer type = Adam
if optimizer == ”SGD”:
optimizer type = SGD
iteration = 0
average f1 = 0.0
for types in magnification list:
if iteration == 0:
load wt = ”Yes”
else:
load wt = ”No”
# Load data.
training images, training labels, validation images, validation labels, testing images,
testing labels =












# Build the model.
for i in range(len(models)):
if models[i]. name == model name:
base model = models[i]
base model = base model(image height=image height,image width
=image width,n channels=n channels,load wt=load wt)
# Add additional layers for classification.
x = base model.output
x = Dense(2048, activation = ’relu’)(x)
x = Dropout(dropout)(x)
if layer1 >0:
x = Dense(layer1, activation = ’relu’)(x)
x = Dropout(dropout)(x)
if layer2 >0:
x = Dense(layer2, activation = ’relu’)(x)
x = Dropout(dropout)(x)
if layer3 >0:
x = Dense(layer3, activation = ’relu’)(x)
out = Dense(8, activation = ’softmax’)(x)
inp = base model.input
model = Model(inp, out)
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# Get the timestamp and set it as model name.
model timestamp = time.strftime(”%H%M%S”) + ’-’ + time.strftime(”%d%m%Y”)





early stopping = EarlyStopping(patience=10, verbose=2)
model checkpoint = ModelCheckpoint(saved model name, save best only=True, ver-
bose=2)
reduce lr = ReduceLROnPlateau(factor=lr decay, patience=5, verbose=2)
history = model.fit generator(
datagen.flow(training images, training labels, batch size=batch size),
steps per epoch=len(training images) / batch size,
validation data=[validation images, validation labels],
callbacks=[early stopping, model checkpoint, reduce lr, SendMetrics()],
epochs=epochs)
# Load the best model.
model = keras.models.load model(saved model name, custom objects=’f1’: f1)
# Get the final validation metrics at last step.
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val loss, val f1, val acc = model.evaluate(validation images,
validation labels) model.save weights(weight name)
print(”The validation metrics at last step: ”)
print(”The validation accuracy for ” + model name + ” with magnification ”+ types +”
is ”, val acc, ” with F1 score of ”, val f1, ”
n”)
print()
# Get the average val f1 score.
average f1 += val f1 / 4.0
# Print the metrics.
if not is search:
# Print the training metrics.
train logits = model.predict(training images)
train pred = np.argmax(train logits, axis=1)
train true = np.argmax(training labels, axis=1)
print(”=”*15 + ” Training metrics ”.format(types) + ”=”*15)
print metrics(train true, train pred)
# Print the validation metrics.
val logits = model.predict(validation images)
val pred = np.argmax(val logits, axis=1)
val true = np.argmax(validation labels, axis=1)
print(”=”*15 + ” Valiation metrics ”.format(types) + ”=”*15)
print metrics(val true, val pred)
# Print the test metrics.
test logits = model.predict(testing images)
test pred = np.argmax(test logits, axis=1)
test true = np.argmax(testing labels, axis=1)
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print(”=”*15 + ” Test metrics ”.format(types) + ”=”*15)
print metrics(test true, test pred)




# report final result
nni.report final result(average f1)
if is search:






# For model architecture.
parser.add argument(”–layer1”, type=int, default=0)
parser.add argument(”–layer2”, type=int, default=0)
parser.add argument(”–layer3”, type=int, default=0)
parser.add argument(”–dropout”, type=float, default=0.3)
# For training hyper-parameters.
parser.add argument(’–batch size’, type=int, default=32)
parser.add argument(’–learning rate’, type=float, default=0.0001)
parser.add argument(’–lr decay’, type=float, default=0.1)
parser.add argument(’–optimizer’, type=str, default=”ADAM”)
parser.add argument(’–epochs’, type=int, default=30)
# For data augmentation.
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parser.add argument(’–horizontal flip’, type=bool,
default=False)
parser.add argument(’–vertical flip’, type=bool, default=False)
parser.add argument(’–rotation range’, type=float, default=0.0)
parser.add argument(’–shear range’, type=float, default=0)
parser.add argument(’–zoom range’, type=float, default=0)
# Identify the phase: train or search.
parser.add argument(’–search’, type=bool, default=True)
args, = parser.parse known args()
return args
if name == ’ main ’:
try:
# get parameters form tuner
tuner params = nni.get next parameter()
params = vars(get params())
params.update(tuner params)
main(params)






import numpy as np
import pandas as pd
import random
import os
import matplotlib.pyplot as plt
import matplotlib.image as mpimg
from skimage.transform import resize
from keras.layers import *
from keras.models import *
from keras import layers
from keras.utils.data utils import get file
from keras import backend as K
from keras.callbacks import EarlyStopping, ModelCheckpoint, ReduceLROnPlateau
from keras.optimizers import Adam
from sklearn.linear model import LogisticRegression
from sklearn.svm import SVC
from sklearn.feature selection import SelectFromModel
from sklearn.model selection import cross validate
from sklearn.metrics import accuracy score, f1 score, roc auc score, confusion matrix
from data processing import data split
from models import *
import tensorflow as tf





tf.random.set random seed(seed value)
models = [vgg16 model, vgg19 model, xception model, resnet model, inception model,
inception resnet model]
def counts from confusion(confusion):
”””
Obtain TP, FN FP, and TN for each class in the confusion matrix
”””
counts list = []
# Iterate through classes and store the counts
for i in range(confusion.shape[0]):
tp = confusion[i, i]
fn mask = np.zeros(confusion.shape)
fn mask[i, :] = 1
fn mask[i, i] = 0
fn = np.sum(np.multiply(confusion, fn mask))
fp mask = np.zeros(confusion.shape)
fp mask[:, i] = 1
fp mask[i, i] = 0
fp = np.sum(np.multiply(confusion, fp mask))
tn mask = 1 - (fn mask + fp mask)
tn mask[i, i] = 0









print metrics(y ture, y pred):
cm = confusion matrix(y ture, y pred).astype(’float’)
results = counts from confusion(cm)
Get the metrics.
met = []
acc avg, precision avg, recall avg, f1 avg, sen avg, spe avg, cc avg = 0, 0, 0, 0, 0, 0, 0
for stat in results:
acc = (stat[’TP’] + stat[’TN’]) / (stat[’TP’] + stat[’TN’] + stat[’FP’] + stat[’FN’])
precision = stat[’TP’] / (stat[’TP’] + stat[’FP’])
recall = stat[’TP’] / (stat[’TP’] + stat[’FN’])
f1 score = 2 * precision * recall / (precision + recall)
sensitivity = stat[’TP’] / (stat[’TP’]+stat[’FN’])
specificity = stat[’TN’] / (stat[’TN’]+stat[’FP’])
cc = ((stat[’TP’]*stat[’TN’]) - (stat[’FN’]*stat[’FP’]))/
((stat[’TP’]+stat[’FN’])*(stat[’TN’]+stat[’FP’])*
(stat[’TP’]+stat[’FP’])*(stat[’TN’]+stat[’FN’]))**0.5
acc avg += acc*1.0/len(results)
precision avg += precision*1.0/len(results)
recall avg += recall*1.0/len(results)
f1 avg += f1 score*1.0/len(results)
sen avg += sensitivity*1.0/len(results)
spe avg += specificity*1.0/len(results)
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# Print the metrics.
print()
print(’0. Confusion matrix: ’)
print(cm)
print()
print (’1. Accuracy mean ’, acc avg)
for i in range (0, len(met)):
print (met[i][’Class’], ’ ’, met[i][’acc’])
print()
print (’2. F1 score mean ’, f1 avg)
for i in range (0, len(met)):
print (met[i][’Class’], ’ ’, met[i][’f1 score’])
print()
print (’3. precision score mean ’, precision avg)
for i in range (0, len(met)):
print (met[i][’Class’], ’ ’, met[i][’precision’])
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print()
print (’4. recall score mean ’, recall avg)
for i in range (0, len(met)):
print (met[i][’Class’], ’ ’, met[i][’recall’])
print()
print (’5. sensitivities score mean ’, sen avg)
for i in range (0, len(met)):
print (met[i][’Class’], ’ ’, met[i][’sensitivity’])
print()
print (’6. specificity score mean ’, spe avg)
for i in range (0, len(met)):
print (met[i][’Class’], ’ ’, met[i][’specificity’])
print()
print (’7. correlation coefficient mean ’, cc avg)
for i in range (0, len(met)):
print (met[i][’Class’], ’ ’, met[i][’cc’])
print()
def f1(y true, y pred):
def recall(y true, y pred):
true positives = K.sum(K.round(K.clip(y true * y pred, 0, 1)))
possible positives = K.sum(K.round(K.clip(y true, 0, 1)))
recall = true positives / (possible positives + K.epsilon())
return recall
def precision(y true, y pred):
true positives = K.sum(K.round(K.clip(y true * y pred, 0, 1)))
predicted positives = K.sum(K.round(K.clip(y pred, 0, 1)))
precision = true positives / (predicted positives + K.epsilon())
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return precision
precision = precision(y true, y pred)
recall = recall(y true, y pred)
return 2*((precision*recall)/(precision+recall+K.epsilon()))
def compile n fit(validation percent, testing percent,
image height, image width, n channels, load wt,dropout =
0.3, model name = ’vgg16 model’, magnification = ’40X’):
Load data.
training images, training labels, validation images,
validation labels, testing images, testing labels =
data split(magnification = magnification, validation percent = validation percent,
testing percent = testing percent)
for i in range(len(models)):
if models[i]. name == model name:
base model = models[i]
base model = base model(image height=image height,image width
=image width,n channels=n channels,load wt=load wt)
x = base model.output
x = Dense(2048, activation = ’relu’)(x)
x = Dropout(dropout)(x)
x = Dense(512, activation = ’relu’)(x)
x = Dropout(dropout)(x)
x = Dense(128, activation = ’relu’)(x)
x = Dropout(dropout)(x)
x = Dense(32, activation = ’relu’)(x)
out = Dense(8, activation = ’softmax’)(x)











early stopping = EarlyStopping(patience=10, verbose=2)
model checkpoint = ModelCheckpoint(model name + ” combine” +”.model”, save best only=True,
verbose=2)
reduce lr = ReduceLROnPlateau(factor=0.1, patience=5, verbose=2) #min lr=0.00001,
epochs = 100
batch size = 64






model checkpoint, reduce lr])
test loss, test acc, test f1 = model.evaluate(testing images, testing labels)
model.save weights(model name + ’ weight 1.h5’)
print(”
nThe test accuracy for ” + model name + ” with magnification ”+ magnification +” is ”,
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[43] T. Araújo, G. Aresta, E. Castro, J. Rouco, P. Aguiar, C. Eloy, A. Polónia, and A.
Campilho, “Classification of breast cancer histology images using convolutional
neural networks,” PloS one, vol. 12, no. 6, e0177544, 2017.
[44] J. Chang, J. Yu, T. Han, H.-j. Chang, and E. Park, “A method for classifying medical
images using transfer learning: A pilot study on histopathology of breast cancer,”
in 2017 IEEE 19th International Conference on e-Health Networking, Applications
and Services (Healthcom), IEEE, 2017, pp. 1–4.
[45] M. Elter and E. Haßlmeyer, “A knowledge-based approach to cadx of mammo-
graphic masses,” in Medical Imaging 2008: Computer-Aided Diagnosis, Interna-
tional Society for Optics and Photonics, vol. 6915, 2008, p. 69150L.
[46] M. T. N. Uppal, “Classification of mammograms for breast cancer detection using
fusion of discrete cosine transform and discrete wavelet transform features.,” 2016.
[47] B. Sahiner, H.-P. Chan, N. Petrick, D. Wei, M. A. Helvie, D. D. Adler, and M. M.
Goodsitt, “Classification of mass and normal breast tissue: A convolution neural
network classifier with spatial domain and texture images,” IEEE transactions on
Medical Imaging, vol. 15, no. 5, pp. 598–610, 1996.
[48] K. Petersen, M. Nielsen, P. Diao, N. Karssemeijer, and M. Lillholm, “Breast tissue
segmentation and mammographic risk scoring using deep learning,” in International
workshop on digital mammography, Springer, 2014, pp. 88–94.
122
[49] A. R. Jamieson, K. Drukker, and M. L. Giger, “Breast image feature learning with
adaptive deconvolutional networks,” in Medical Imaging 2012: Computer-Aided Di-
agnosis, International Society for Optics and Photonics, vol. 8315, 2012, p. 831 506.
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